Skip to content
sellWeak10b5-1 plan

Marshall Fordyce sold $2.0M of VERA

PRESIDENT AND CEO at Vera Therapeutics, Inc.. 46,250 shares at an average of $42.30, traded Jul 7, 2026, filed Jul 9, 2026.

Warning score
35
Value
$2.0M
46,250 shares
Holdings after
151,994
-23% from before
From 52-week low
+123%
low $19.25, close $42.96
From 52-week high
-23%
high $55.67, as of Jul 7, 2026

Score components

  • Role
    CEO
    +25
  • Trade size
    $2.0M at market
    +25
  • Share of holdings sold
    Sold 23% of holdings
    +5
  • Cluster
    No other insider selling within 14 days
    0
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

VERAOct 12, 2026 · close 27.72
Since filing Jul 9, 2026: -34.7%SPY +3.8% · excess -38.5%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001859453-26-000010, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jul 7, 2026SOpen-market sale
Class A Common Stock10b5-1
-1,000$40.78$41k197,244Jul 9, 2026
Jul 7, 2026SOpen-market sale
Class A Common Stock10b5-1
-32,550$42.07$1.4M164,694Jul 9, 2026
Jul 7, 2026SOpen-market sale
Class A Common Stock10b5-1
-10,500$42.86$450k154,194Jul 9, 2026
Jul 7, 2026SOpen-market sale
Class A Common Stock10b5-1
-2,200$43.59$96k151,994Jul 9, 2026

Related signals

Other insiders at Vera Therapeutics, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
11Weak
VERAsell10b5-1
Vera Therapeutics, Inc.
Marshall Fordyce
PRESIDENT AND CEO
$685k
18,500 shares
-7%
10Weak
VERAsell10b5-1
Vera Therapeutics, Inc.
Marshall Fordyce
PRESIDENT AND CEO
$650k
18,500 shares
-7%
11Weak
VERAsell10b5-1
Vera Therapeutics, Inc.
Marshall Fordyce
PRESIDENT AND CEO
$680k
18,500 shares
-7%
11Weak
VERAsell10b5-1
Vera Therapeutics, Inc.
Marshall Fordyce
PRESIDENT AND CEO
$702k
18,500 shares
-7%
20Weak
VERAsell10b5-1
Vera Therapeutics, Inc.
Marshall Fordyce
PRESIDENT AND CEO
$2.0M
46,250 shares
-16%
26Weak
VERAsell10b5-1
Vera Therapeutics, Inc.
Marshall Fordyce
PRESIDENT AND CEO
$702k
18,500 shares
-9%
26Weak
VERAsell10b5-1
Vera Therapeutics, Inc.
Marshall Fordyce
PRESIDENT AND CEO
$680k
18,500 shares
-8%
30Weak
VERAsell10b5-1
Vera Therapeutics, Inc.
Marshall Fordyce
PRESIDENT AND CEO
$1.0M
22,951 shares
-9%
39Weak
VERAsell 7
Vera Therapeutics, Inc.
Robert Brenner
Chief Medical Officer
$90k
2,151 shares
-4%
61Notable
VERAsell 7
Vera Therapeutics, Inc.
Marshall Fordyce
PRESIDENT AND CEO
$711k
16,925 shares
-6%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Marshall Fordyce sold $2.0M of VERA | InsiderTell